{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:49:37Z","timestamp":1794574177140,"version":"4.9.1"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To report long-term follow-up of patients with multiple endocrine neoplasia type 1 (MEN1) and nonfunctioning pancreatic neuroendocrine tumors (NF-PET).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Pancreaticoduodenal tumors occur in almost all patients with MEN1 and are a major cause of death. The natural history and clinical outcome are poorly defined, and management is still controversial for small NF-PET.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Clinical outcome and tumor progression were analyzed in 46 patients with MEN1 with 2\u200acm or smaller NF-PET who did not have surgery at the time of initial diagnosis. Survival data were analyzed using the Kaplan-Meier method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Forty-six patients with MEN1 were followed prospectively for 10.7\u200a\u00b1\u200a4.2 (mean\u200a\u00b1\u200astandard deviation) years. One patient was lost to follow-up and 1 died from a cause unrelated to MEN1. Twenty-eight patients had stable disease and 16 showed significant progression of pancreaticoduodenal involvement, indicated by increase in size or number of tumors, development of a hypersecretion syndrome, need for surgery (7 patients), and death from metastatic NF-PET (1 patient). The mean event-free survival was 13.9\u200a\u00b1\u200a1.1 years after NF-PET diagnosis. At last follow-up, none of the living patients who had undergone surgery or follow-up had evidence of metastases on imaging studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our study shows that conservative management for patients with MEN1 with NF-PET of 2\u200acm or smaller is associated with a low risk of disease-specific mortality. The decision to recommend surgery to prevent tumor spread should be balanced with operative mortality and morbidity, and patients should be informed about the risk-benefit ratio of conservative versus aggressive management when the NF-PET represents an intermediate risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/sla.0000000000002191","type":"journal-article","created":{"date-parts":[[2017,3,4]],"date-time":"2017-03-04T09:03:46Z","timestamp":1488618226000},"page":"158-164","source":"Crossref","is-referenced-by-count":106,"title":["Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small \u22642 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study"],"prefix":"10.1097","volume":"268","author":[{"given":"Frederic","family":"Triponez","sequence":"first","affiliation":[{"name":"Department of Thoracic and Endocrine Surgery, University Hospitals of Geneva and Faculty of Medicine of Geneva, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira M.","family":"Sadowski","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Endocrine Surgery, University Hospitals of Geneva and Faculty of Medicine of Geneva, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Pattou","sequence":"additional","affiliation":[{"name":"Department of General and Endocrine Surgery, University Hospital of Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Cardot-Bauters","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University Hospital of Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Miralli\u00e9","sequence":"additional","affiliation":[{"name":"Department of Digestive and Endocrine Surgery, University Hospital of Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00eblle","family":"Le Bras","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University Hospital of Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Sebag","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, La Conception University Hospital, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Niccoli","sequence":"additional","affiliation":[{"name":"Institut Paoli-Calmettes, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Deguelte","sequence":"additional","affiliation":[{"name":"Department of Digestive and Endocrine Surgery, University Hospital of Reims, Reims, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Cadiot","sequence":"additional","affiliation":[{"name":"Department of Hepato-Gastroenterology and Digestive Oncology, University Hospital of Reims, Reims, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Poncet","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospital of Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Lifante","sequence":"additional","affiliation":[{"name":"Department of Digestive and Endocrine Surgery, University Hospital of Lyon Sud and 2\/EA 7425 HESPER, Health Services and Performance Research, University Claude Bernard Lyon 1, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Borson-Chazot","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hospital Louis Pradel, University Lyon I, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Chaffanjon","sequence":"additional","affiliation":[{"name":"Department of Thoracic, Vascular and Endocrine Surgery, University Hospital of Grenoble, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Chabre","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetology, University Hospital of Grenoble, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Menegaux","sequence":"additional","affiliation":[{"name":"Department of Digestive and Endocrine Surgery, University Hospital La Piti\u00e9 Salp\u00e9tri\u00e8re, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Baudin","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy, University of Paris Sud, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Ruszniewski","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Pancreatology, Beaujon Hospital, University Paris 7, Clichy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Du Boullay","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, General Hospital of Chamb\u00e9ry, Chamb\u00e9ry, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Goudet","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, University Hospital of Dijon, and INSERM, U866, Epidemiology and Clinical Research in Digestive Oncology Team, and INSERM, CIC1432, Clinical Epidemiology Unit, University Hospital of Dijon, Clinical Investigation Center, Clinical Epidemiology\/Clinical Trials Unit, Dijon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230923","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/MD.0b013e3182954af1","article-title":"Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1\/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors","volume":"92","author":"Ito","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"R2-20230923","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00268-009-0290-1","article-title":"Risk factors and causes of death in MEN1 disease. A GTE (Groupe d\u2019Etude des Tumeurs Endocrines) cohort study among 758 patients","volume":"34","author":"Goudet","year":"2010","journal-title":"World J Surg"},{"key":"R3-20230923","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R4-20230923","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1572-0241.2006.00367.x","article-title":"Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1","volume":"101","author":"Thomas-Marques","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R5-20230923","doi-asserted-by":"crossref","first-page":"R121","DOI":"10.1530\/ERC-13-0482","article-title":"Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis","volume":"21","author":"Pieterman","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"R6-20230923","first-page":"63","article-title":"Management of pancreatic neuroendocrine tumors in patients with MEN 1","volume":"4","author":"Sadowski","year":"2015","journal-title":"Gland Surg"},{"key":"R7-20230923","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s00268-004-7609-8","article-title":"Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors","volume":"28","author":"Dralle","year":"2004","journal-title":"World J Surg"},{"key":"R8-20230923","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1067\/msy.2000.109727","article-title":"Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance?","volume":"128","author":"Bartsch","year":"2000","journal-title":"Surgery"},{"key":"R9-20230923","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.sla.0000189549.51913.d8","article-title":"Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1","volume":"242","author":"Bartsch","year":"2005","journal-title":"Ann Surg"},{"key":"R10-20230923","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00423-011-0828-1","article-title":"Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1","volume":"396","author":"Lopez","year":"2011","journal-title":"Langenbecks Arch Surg"},{"key":"R11-20230923","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/SLA.0b013e3182536339","article-title":"Partial pancreaticoduodenectomy can provide cure for duodenal gastrinoma associated with multiple endocrine neoplasia type 1","volume":"257","author":"Lopez","year":"2013","journal-title":"Ann Surg"},{"key":"R12-20230923","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1159\/000443613","article-title":"Active surveillance versus surgery of nonfunctioning pancreatic neuroendocrine neoplasms \u22642 cm in MEN1 patients","volume":"103","author":"Partelli","year":"2016","journal-title":"Neuroendocrinology"},{"key":"R13-20230923","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000443171","article-title":"ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology"},{"key":"R14-20230923","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s00268-005-0354-9","article-title":"Is surgery beneficial for MEN1 patients with small (< or = 2\u200acm), nonfunctioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE","volume":"30","author":"Triponez","year":"2006","journal-title":"World J Surg"},{"key":"R15-20230923","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.sla.0000197715.96762.68","article-title":"Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas","volume":"243","author":"Triponez","year":"2006","journal-title":"Ann Surg"},{"key":"R16-20230923","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/EJE-10-0950","article-title":"Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d\u2019etude des Tumeurs Endocrines","volume":"165","author":"Goudet","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"R17-20230923","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archsurg.1993.01420180085016","article-title":"Cause of death in multiple endocrine neoplasia type 1","volume":"128","author":"Wilkinson","year":"1993","journal-title":"Arch Surg"},{"key":"R18-20230923","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s002689900438","article-title":"Lethality of multiple endocrine neoplasia type I","volume":"22","author":"Doherty","year":"1998","journal-title":"World J Surg"},{"key":"R19-20230923","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s002680010237","article-title":"Are patients with multiple endocrine neoplasia type I prone to premature death?","volume":"24","author":"Dean","year":"2000","journal-title":"World J Surg"},{"key":"R20-20230923","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00268-009-9980-y","article-title":"Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines)","volume":"33","author":"Goudet","year":"2009","journal-title":"World J Surg"},{"key":"R21-20230923","doi-asserted-by":"crossref","first-page":"159.e2","DOI":"10.1016\/j.gie.2014.09.037","article-title":"EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1","volume":"81","author":"Van Asselt","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"R22-20230923","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jamcollsurg.2015.04.005","article-title":"Results of (68)Gallium-DOTATATE PET\/CT scanning in patients with multiple endocrine neoplasia type 1","volume":"221","author":"Sadowski","year":"2015","journal-title":"J Am Coll Surg"},{"key":"R23-20230923","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/01.pas.0000194044.01104.25","article-title":"Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome","volume":"30","author":"Anlauf","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R24-20230923","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000367850","article-title":"The status of neuroendocrine tumor imaging: from darkness to light?","volume":"101","author":"Bodei","year":"2015","journal-title":"Neuroendocrinology"},{"key":"R25-20230923","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.1210\/jc.2013-1768","article-title":"Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life","volume":"99","author":"Goncalves","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-20230923","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1677\/erc.1.01220","article-title":"Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study","volume":"13","author":"Kann","year":"2006","journal-title":"Endocr Relat Cancer"},{"issue":"(Suppl 1)","key":"R27-20230923","doi-asserted-by":"crossref","first-page":"173","DOI":"10.6061\/clinics\/2012(Sup01)29","article-title":"Surgical management of pancreatico-duodenal tumors in multiple endocrine neoplasia syndrome type 1","volume":"67","author":"Akerstrom","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"key":"R28-20230923","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00595-012-0376-5","article-title":"Surgery for a gastroenteropancreatic neuroendocrine tumor (GEPNET) in multiple endocrine neoplasia type 1","volume":"43","author":"Hanazaki","year":"2013","journal-title":"Surg Today"},{"key":"R30-20230923","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bpg.2012.12.003","article-title":"Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances","volume":"26","author":"Ito","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R31-20230923","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5009\/gnl.2012.6.3.287","article-title":"The current strategy for managing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1","volume":"6","author":"Niina","year":"2012","journal-title":"Gut Liver"},{"key":"R32-20230923","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1245\/s10434-015-4986-1","article-title":"Observation versus resection for small asymptomatic pancreatic neuroendocrine tumors: a matched case-control study","volume":"23","author":"Sadot","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R33-20230923","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.surg.2015.04.035","article-title":"Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: do size and symptoms matter?","volume":"158","author":"Sallinen","year":"2015","journal-title":"Surgery"},{"key":"R34-20230923","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.surg.2015.10.013","article-title":"Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumors","volume":"159","author":"Rosenberg","year":"2015","journal-title":"Surgery"},{"key":"R35-20230923","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.surg.2015.10.003","article-title":"Is the 2-cm size cutoff relevant for small nonfunctioning pancreatic neuroendocrine tumors: a French multicenter study","volume":"159","author":"Regenet","year":"2016","journal-title":"Surgery"},{"key":"R36-20230923","doi-asserted-by":"crossref","first-page":"e1404","DOI":"10.1097\/MD.0000000000001404","article-title":"Overestimated oncologic significance of lymph node metastasis in G1 nonfunctioning neuroendocrine tumor in the left side of the pancreas","volume":"94","author":"Yoo","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"R37-20230923","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s11605-013-2360-9","article-title":"Nonfunctional pancreatic neuroendocrine tumors <2 cm on preoperative imaging are associated with a low incidence of nodal metastasis and an excellent overall survival","volume":"17","author":"Toste","year":"2013","journal-title":"J Gastrointest Surg"},{"key":"R38-20230923","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.surg.2004.06.049","article-title":"The surgical management of MEN-1 pancreatoduodenal neuroendocrine disease","volume":"136","author":"Hausman","year":"2004","journal-title":"Surgery"},{"key":"R39-20230923","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.surg.2009.06.038","article-title":"Completion pancreatectomy and duodenectomy for recurrent MEN-1 pancreaticoduodenal endocrine neoplasms","volume":"146","author":"Gauger","year":"2009","journal-title":"Surgery"},{"key":"R40-20230923","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000326164","article-title":"Presentation and outcome of pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1 syndrome","volume":"94","author":"Davi","year":"2011","journal-title":"Neuroendocrinology"},{"key":"R41-20230923","article-title":"Early and late complications after surgery for MEN1-related nonfunctioning pancreatic neuroendocrine tumors","author":"Nell","year":"2016","journal-title":"Ann Surg"},{"key":"R42-20230923","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.dld.2011.09.014","article-title":"Magnetic resonance imaging versus endoscopic ultrasonography for the detection of pancreatic tumours in multiple endocrine neoplasia type 1","volume":"44","author":"Barbe","year":"2012","journal-title":"Dig Liver Dis"},{"key":"R43-20230923","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2217\/ije.15.29","article-title":"Imaging in multiple endocrine neoplasia type 1: recent studies show enhanced sensitivities but increased controversies","volume":"3","author":"Ito","year":"2016","journal-title":"Int J Endocr Oncol"},{"key":"R44-20230923","doi-asserted-by":"crossref","first-page":"453.e5","DOI":"10.1053\/j.gastro.2013.10.020","article-title":"Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors","volume":"146","author":"Marinoni","year":"2014","journal-title":"Gastroenterology"}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000658-201807000-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:03:09Z","timestamp":1786039389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000658-201807000-00025"}},"subtitle":["Association Francophone de Chirurgie Endocrinienne &amp; Groupe d\u2019Etude des Tumeurs Endocrines"],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/sla.0000000000002191","relation":{},"ISSN":["0003-4932","1528-1140"],"issn-type":[{"value":"0003-4932","type":"print"},{"value":"1528-1140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}